🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction

RecruitingEARLY Phase 1Ages 18 Years - 80 YearsAllMedical College of Wisconsin
NCT05593549 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to examine the role of autophagy on microvascular function in adults with Type 2 Diabetes. The main question it aims to answer are: * Does presence of Type 2 Diabetes reduce autophagy and impair microvascular function? * Does exposure to high glucose impair autophagy and subsequently microvascular function? Participants will undergo 2 study days. The primary outcome will be in vivo microvascular function testing. Following the first study day participants will undergo either supplementation with trehalose, an autophagy activator, or placebo for 14 days. The second study day will test in vivo microvascular function.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Participants must be between 18-80 yrs. of age and will be delineated into two groups * Clinical Diagnosis of Type 2 Diabetes Mellitus in accordance with American Diabetes Association (ADA) guidelines (Type 2 Diabetic group) * Otherwise healthy individuals (Healthy control group) with no more than 1 cardiovascular risk factor Exclusion Criteria: * Uncontrolled hypertension * Current Tobacco use or within last 6 months * BMI \> 35 * Hyperlipidemia * Hypercholesterolemia * Type 1 Diabetes * Use of anti-coagulant drugs, or anti-platelet drugs * Symptomatic coronary artery disease * Heart Failure * Renal Impairment * Hormone Replacement Therapy * History of Retinopathy * Documented Neuromuscular Disorders * Porphyria Cutanea Tarda (blistering of skin to sun; photosensitivity) * Pregnancy (Young Female subjects) * Allergies to Povidone Iodine * Use Erectile Dysfunction Medication in the past 6 months * Use of Topical/non-topical Steroids in last 6 months * Active Anti-Cancer Treatment or Treatment within last 12 months * Active COVID-19 or within the past 3 months * Gender Reassignment Therapy
💊

What it tests

  • Trehalose
  • Placebo
📍

Where

1 site
Medical College of Wisconsin
Milwaukee, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy